Follow the ACRUX LIMITED stock price and the full directors' dealings record of the company, a publicly traded company based in Australia. Shares are quoted on the AU market, under the supervision of ASX. Market capitalisation: €5.9m. The latest transaction was disclosed on 23 July 2026 (Purchase). Among the most active insiders: Ross Dobinson. The full history is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
ACRUX LIMITED is a company listed on the XASX market, specializing in the development of pharmaceutical products. It focuses on innovative solutions to improve patient health.